Published in Law and Health Weekly, June 16th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at GTC Biotherapeutics, Inc.
Report 1: GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) announced that it has been granted a non-exclusive worldwide license from Start Licensing, Inc., a joint venture between Geron Corporation (Nasdaq: GERN) and Exeter Life Sciences, Inc., for the patents and patent applications developed by the Roslin Institute to apply nuclear transfer to the production of therapeutic proteins in the milk of transgenic animals. Nuclear transfer may be utilized, as an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.